Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
2009 · British Journal of Cancer · 166 citations
https://doi.org/10.1038/sj.bjc.6605293
M
Merrill J. Egorin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
474
Papers
21.7K
Citations
71
h-index
283
i10-index
Merrill J. Egorin is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Cancer therapeutics and mechanisms & Chronic Myeloid Leukemia Treatments. The author has an h-index of 71, co-authored 403 publications.
Papers by this author
worksA Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours
2009 · European Journal of Cancer · 36 citations
https://doi.org/10.1016/j.ejca.2009.05.008
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia
2012 · Pharmacogenetics and Genomics · 27 citations
https://doi.org/10.1097/fpc.0b013e32835b16d8
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building
2012 · Journal of Pharmacokinetics and Pharmacodynamics · 26 citations
https://doi.org/10.1007/s10928-012-9258-0
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
2012 · British Journal of Cancer · 17 citations
https://doi.org/10.1038/bjc.2012.312
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors
2012 · Cancer Chemotherapy and Pharmacology · 6 citations
https://doi.org/10.1007/s00280-012-1859-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat